A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):305-314. doi: 10.5588/ijtld.20.0513.
Int J Tuberc Lung Dis. 2021.
PMID: 33762075
Free PMC article.
Clinical Trial.